Vaccines for COVID-19: the current state of play

Field	Value	Language
dc.contributor.author	Koirala, Archana	en
dc.contributor.author	Joo, Ye Jin	en
dc.contributor.author	Khatami, Ameneh	en
dc.contributor.author	Chiu, Clayton	en
dc.contributor.author	Britton, Philip N	en
dc.date.accessioned	2020-07-09
dc.date.available	2020-07-09
dc.date.issued	2020	en
dc.identifier.uri	https://hdl.handle.net/2123/22811
dc.description.abstract	There is a strong consensus globally that a COVID-19 vaccine is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. Here, we review vaccine types, and progress with 10 vaccine candidates against SARS-CoV-2 – the virus that causes COVID-19 - currently undergoing early phase human trials. We also consider the many challenges of developing and deploying a new vaccine on a global scale, and recommend caution with respect to our expectations of the timeline that may be ahead.	en
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	Vaccines for COVID-19: the current state of play	en
dc.type	Article	en
dc.identifier.doi	10.1111/imj.14867
usyd.faculty	Faculty of Medicine and Health, Sydney Medical School	en

Associated file/s

There are no files associated with this item.